Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2025-05-09 Declaration of Voting R…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
OXUR-PR_Voting-rights-ENG_20250509.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release announcing a capital increase resulting from the conversion of convertible bonds by Atlas Special Opportunities, LLC. It specifically provides the updated total number of voting rights and shares (the 'denominator') as required by Belgian transparency regulations. While it mentions a capital increase, the primary purpose of this specific filing is to update the market on the share count and voting rights structure following the issuance of new shares. This aligns with the 'Share Issue/Capital Change' category, as it details the issuance of new ordinary shares and the resulting change in capital structure.
2025-05-09 English
OXUR-PR_Voting-rights-NED_20250509.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a regulatory announcement from Oxurion NV regarding a change in the total number of voting rights (denominator) following a capital increase resulting from the conversion of convertible bonds by Atlas Special Opportunities, LLC. This type of filing is specifically categorized as a 'Share Issue/Capital Change' (SHA) because it details the issuance of new shares and the resulting change in the company's capital structure and voting rights denominator.
2025-05-09 Dutch
OXUR_PR-re-termination-discussions-French-CRO-and-ongoing-discussions-re-new-potential-transaction_EN_20250425_exe.pdf
M&A Activity Classification · 100% confidence The document is a press release announcing the termination of one acquisition negotiation and the continuation of another. This falls under M&A activity. Since it is an announcement regarding merger/acquisition proposals and status, it fits the 'TAR' (M&A Activity) category perfectly.
2025-04-25 English
OXUR_PR-re-termination-discussions-French-CRO-and-ongoing-discussions-re-new-potential-transaction_FR_20250425_exe (1).pdf
M&A Activity Classification · 100% confidence The document is a press release from Oxurion announcing the termination of a previously discussed acquisition (July 2024) and the continuation of negotiations for a new acquisition (March 2025). Since the document focuses on merger and acquisition activity, it falls under the M&A Activity category.
2025-04-25 French
OXUR_PR-re-termination-discussions-French-CRO-and-ongoing-discussions-re-new-potential-transaction_NL_20250425_exe.pdf
M&A Activity Classification · 100% confidence The document is a press release from Oxurion NV regarding the termination of a previously announced acquisition (July 2024) and the continuation of negotiations for a new acquisition (March 2025). This falls under M&A activity, specifically the announcement of merger/acquisition status updates. According to the provided definitions, M&A activity is classified under the code 'TAR'.
2025-04-25 Dutch
OXURION-Remuneration-Policy-2025_exe.pdf
Remuneration Information Classification · 100% confidence The document is titled 'Oxurion Remuneration Policy 2025'. It outlines the company's policies regarding the compensation of board members and executives, including guiding principles, market benchmarking, and specific remuneration elements like base compensation, pensions, and benefits. This document is a formal policy statement regarding executive and director compensation, which falls under the 'Remuneration Information' category (DEF 14A).
2025-04-11 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.